Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Elicio Therapeutics Inc.
Swot
Elicio Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Elicio Therapeutics Inc. has 13 Strengths, 7 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(7)
Opportunity
(0)
Threats
(3)
Others
(1)
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
MACD crossed below zero line previous end of day
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Top Losers
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
